A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Dimethyltryptamine
Azimilide
The risk or severity of QTc prolongation can be increased when Azimilide is combined with Glasdegib.
Dimethyltryptamine
Fluspirilene
The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Glasdegib.
Dimethyltryptamine
Prenylamine
The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Glasdegib.
Dimethyltryptamine
Terlipressin
The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Glasdegib.
Dimethyltryptamine
Aceprometazine
The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Glasdegib.
Dimethyltryptamine
Probucol
The risk or severity of QTc prolongation can be increased when Probucol is combined with Glasdegib.
Dimethyltryptamine
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Glasdegib.
Dimethyltryptamine
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Glasdegib.
Dimethyltryptamine
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Glasdegib.
Embutramide
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Dacomitinib.
Embutramide
Filgotinib
The serum concentration of Dacomitinib can be increased when it is combined with Filgotinib.
Embutramide
Pralsetinib
The serum concentration of Pralsetinib can be increased when it is combined with Dacomitinib.
Embutramide
Satralizumab
The serum concentration of Dacomitinib can be decreased when it is combined with Satralizumab.
Embutramide
Oliceridine
The serum concentration of Oliceridine can be increased when it is combined with Dacomitinib.
Embutramide
Abametapir
The serum concentration of Dacomitinib can be increased when it is combined with Abametapir.
Embutramide
Sacituzumab govitecan
The serum concentration of Sacituzumab govitecan can be increased when it is combined with Dacomitinib.
Embutramide
Ozanimod
Dacomitinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.
Embutramide
Rimegepant
The serum concentration of Rimegepant can be increased when it is combined with Dacomitinib.
Embutramide
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Dacomitinib.
Embutramide
Lumateperone
The serum concentration of Lumateperone can be increased when it is combined with Dacomitinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3